Author:
Hamers Iris M.H.,Brand Bodyl A.,Begemann Marieke J.H.,Weickert Cynthia S.,Weickert Thomas W.,Sommer Iris E.C.
Reference34 articles.
1. Relationship between plasma levels of prolactin and the severity of negative symptoms in patients with schizophrenia;Ates;Klinik Psikofarmakoloji Bulteni,2015
2. Chronic antipsychotic treatment modulates aromatase (CYP19A1) expression in the male rat brain;Bogus;J. Mol. Neurosci.,2019
3. Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a study protocol;Brand;Contemp. Clin. Trials Commun.,2020
4. Brand, B.A., de Boer, J.N., Willemse, E., Weickert, C.S., Sommer, I.E., Weickert, T., (in press) Antipsychotic-induced Prolactin Elevation in Premenopausal Women With Schizophrenia: Associations With Estrogen, Disease Severity and Cognition. Arch Womens Ment Health.
5. Efficacy of iloperidone in schizophrenia: a PANSS five-factor analysis;Citrome;Schizophr. Res.,2011